Related Experiment Video
Updated: Jun 27, 2026

05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Sentinel Lymph Node Mapping Compared with Selective Lymph Node Sampling in the Surgical Staging of Endometrial
Vlad Alexandru Gâta1,2, Radu Alexandru Ilieș3, Ana Maria Mureșan-Bădescu3
1Department of Oncological Surgery, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Diagnostics (Basel, Switzerland)
|June 26, 2026
Summary
Sentinel lymph node (SLN) mapping is effective for staging endometrial cancer, showing similar metastasis rates to selective lymph node sampling (SLNS). Blue dye (BD) offers better bilateral detection than indocyanine green (ICG).
Area of Science:
- Gynecologic Oncology
- Surgical Oncology
- Pathology
Background:
- Lymph node assessment is crucial for endometrial cancer surgical staging.
- Sentinel lymph node (SLN) mapping is increasingly used as an alternative to lymphadenectomy.
Purpose of the Study:
- To compare SLN mapping and selective lymph node sampling (SLNS) in endometrial cancer.
- To evaluate clinicopathological characteristics and the association between tumor stage and nodal involvement.
Main Methods:
- Prospective observational cohort study of 137 endometrial cancer patients.
- Surgical staging involved SLN mapping (indocyanine green or blue dye) or SLNS.
- Analysis of clinical, surgical, and histopathological data.
Main Results:
- SLNS yielded more lymph nodes (10) than SLN mapping (4).
- Overall nodal metastasis rate was 9.5% with no significant difference between techniques.
- Blue dye (BD) showed higher bilateral nodal detection rates (73.3%) than indocyanine green (ICG) (51.2%).
- Nodal involvement significantly increased with advanced pathological T stage (0% in T1a to 40.0% in T3a).
Conclusions:
- SLN mapping demonstrated comparable nodal metastasis detection rates to SLNS.
- Blue dye (BD) exhibited superior bilateral detection compared to ICG.
- Tumor stage remains a significant predictor of lymph node involvement in endometrial cancer.
